Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

The Federal Drug Administration announced two different tomato recalls affecting 14 states for the possible contamination of ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

A medication already prescribed to relieve menopausal symptoms could also help prevent invasive breast cancer. That's the ...

The Food and Drug Administration (FDA) has approved Khindivi ™ (hydrocortisone) oral solution as a replacement therapy in ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).

and was the basis of the recent U.S. Food and Drug Administration’s (FDA) accelerated approval of the combination in KRAS-mutated recurrent LGSOC. LGSOC is a rare form of ovarian cancer that ...

The FDA has approved Novavax's ... children under 12 are still pending. The approval marks a significant step for Novavax, despite earlier delays attributed to the vaccine's composition. The U.S. Food ...

a drug that mimics a person’s natural hormones affecting hunger, digestion and feelings of fullness. It was approved by the FDA in 2017 to treat obesity in people 12 and older. The most common ...